Insulin glulisine is a new analogue of human insulin designed for use as a rapid-acting insulin. It is effective in improving post-meal glycaemic control, and in reducing the risk of fasting hypoglycaemia in patients with diabetes.
Read more: please click below link
MP-0310 Drug Profile.pdf (application/pdf Object)
Tidak ada komentar:
Posting Komentar